DNA Landbrug, Stege ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  0.0% 1.7% 1.5% 2.4% 1.6%  
Credit score (0-100)  0 71 75 62 75  
Credit rating  N/A A A BBB A  
Credit limit (kDKK)  0.0 5.9 31.8 0.1 25.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 3,184 6,738 2,374 4,234  
EBITDA  0.0 2,612 5,364 1,133 2,701  
EBIT  0.0 2,342 4,880 531 2,037  
Pre-tax profit (PTP)  0.0 1,963.6 4,596.5 53.4 691.8  
Net earnings  0.0 1,512.5 3,658.9 41.5 470.7  
Pre-tax profit without non-rec. items  0.0 1,964 4,597 53.4 692  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 11,555 15,571 16,346 28,123  
Shareholders equity total  0.0 3,740 7,399 7,441 7,911  
Interest-bearing liabilities  0.0 13,616 13,368 14,927 26,872  
Balance sheet total (assets)  0.0 18,676 23,368 25,170 37,075  

Net Debt  0.0 10,759 13,368 14,927 26,426  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 3,184 6,738 2,374 4,234  
Gross profit growth  0.0% 0.0% 111.6% -64.8% 78.4%  
Employees  0 2 3 3 4  
Employee growth %  0.0% 0.0% 50.0% 0.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 18,676 23,368 25,170 37,075  
Balance sheet change%  0.0% 0.0% 25.1% 7.7% 47.3%  
Added value  0.0 2,612.5 5,363.7 1,013.8 2,701.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 11,319 3,499 172 11,114  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 73.6% 72.4% 22.4% 48.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 12.5% 23.2% 2.3% 7.0%  
ROI %  0.0% 13.0% 24.7% 2.5% 7.5%  
ROE %  0.0% 40.4% 65.7% 0.6% 6.1%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 20.0% 31.7% 29.6% 21.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 411.9% 249.2% 1,317.5% 978.3%  
Gearing %  0.0% 364.0% 180.7% 200.6% 339.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 5.6% 2.1% 3.5% 7.1%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.9 0.6 0.7 0.5  
Current Ratio  0.0 1.5 1.6 1.6 1.6  
Cash and cash equivalent  0.0 2,856.3 0.0 0.0 446.7  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 2,403.1 2,896.8 3,190.6 3,387.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 1,306 1,788 338 675  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 1,306 1,788 378 675  
EBIT / employee  0 1,171 1,627 177 509  
Net earnings / employee  0 756 1,220 14 118